BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grozdanovic M, Laffey KG, Abdelkarim H, Hitchinson B, Harijith A, Moon HG, Park GY, Rousslang LK, Masterson JC, Furuta GT, Tarasova NI, Gaponenko V, Ackerman SJ. Novel peptide nanoparticle-biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness. J Allergy Clin Immunol 2019;143:669-680.e12. [PMID: 29778505 DOI: 10.1016/j.jaci.2018.05.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Chen S, Chen G, Xu F, Sun B, Chen X, Hu W, Li F, Syeda MZ, Chen H, Wu Y, Wu P, Jing R, Geng X, Zhang L, Tang L, Li W, Chen Z, Zhang C, Sun J, Chen W, Shen H, Ying S. Treatment of allergic eosinophilic asthma through engineered IL-5-anchored chimeric antigen receptor T cells. Cell Discov 2022;8:80. [PMID: 35973984 DOI: 10.1038/s41421-022-00433-y] [Reference Citation Analysis]
2 Filippone RT, Dargahi N, Eri R, Uranga JA, Bornstein JC, Apostolopoulos V, Nurgali K. Potent CCR3 Receptor Antagonist, SB328437, Suppresses Colonic Eosinophil Chemotaxis and Inflammation in the Winnie Murine Model of Spontaneous Chronic Colitis. IJMS 2022;23:7780. [DOI: 10.3390/ijms23147780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shao Z, Tan Y, Shen Q, Hou L, Yao B, Qin J, Xu P, Mao C, Chen L, Zhang H, Shen D, Zhang C, Li W, Du X, Li F, Chen Z, Jiang Y, Xu HE, Ying S, Ma H, Zhang Y, Shen H. Molecular insights into ligand recognition and activation of chemokine receptors CCR2 and CCR3. Cell Discov 2022;8. [DOI: 10.1038/s41421-022-00403-4] [Reference Citation Analysis]
4 Asano T, Suzuki H, Goto N, Tanaka T, Kaneko MK, Kato Y. Establishment of Novel Anti-Mouse CCR3 Monoclonal Antibodies (C3Mab-6 and C3Mab-7) by N-terminal Peptide Immunization. Monoclon Antib Immunodiagn Immunother 2022;41:94-100. [PMID: 35471054 DOI: 10.1089/mab.2021.0065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Asano T, Suzuki H, Tanaka T, Saito M, Li G, Goto N, Nanamiya R, Kaneko MK, Kato Y. C3Mab-3: A Monoclonal Antibody for Mouse CC Chemokine Receptor 3 for Flow Cytometry. Monoclon Antib Immunodiagn Immunother 2022;41:74-9. [PMID: 35471049 DOI: 10.1089/mab.2021.0062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ahmad A. Pharmacological Strategies and Recent Advancement in Nano-Drug Delivery for Targeting Asthma. Life 2022;12:596. [DOI: 10.3390/life12040596] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yuan J, Liu Y, Yu J, Dai M, Zhu Y, Bao Y, Peng H, Liu K, Zhu X. Gene knockdown of CCR3 reduces eosinophilic inflammation and the Th2 immune response by inhibiting the PI3K/AKT pathway in allergic rhinitis mice. Sci Rep 2022;12:5411. [PMID: 35354939 DOI: 10.1038/s41598-022-09467-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Li Y, Sun J, Li J, Liu K, Zhang H. Engineered protein nanodrug as an emerging therapeutic tool. Nano Res . [DOI: 10.1007/s12274-022-4103-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Racca F, Pellegatta G, Cataldo G, Vespa E, Carlani E, Pelaia C, Paoletti G, Messina MR, Nappi E, Canonica GW, Repici A, Heffler E. Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets. Front Physiol 2022;12:815842. [DOI: 10.3389/fphys.2021.815842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Dai M, Zhu X, Yu J, Yuan J, Zhu Y, Bao Y, Yong X. CCR3 gene knockout in bone marrow cells ameliorates combined allergic rhinitis and asthma syndrome (CARAS) by reducing airway inflammatory cell infiltration and Th2 cytokines expression in mice model. Int Immunopharmacol 2022;104:108509. [PMID: 34998035 DOI: 10.1016/j.intimp.2021.108509] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Li N, Mirzakhani H, Kiefer A, Koelle J, Vuorinen T, Rauh M, Yang Z, Krammer S, Xepapadaki P, Lewandowska-Polak A, Lukkarinen H, Zhang N, Stanic B, Zimmermann T, Kowalski ML, Jartti T, Bachert C, Akdis M, Papadopoulos NG, Raby BA, Weiss ST, Finotto S. Regulated on Activation, Normal T cell Expressed and Secreted (RANTES) drives the resolution of allergic asthma. iScience 2021;24:103163. [PMID: 34693221 DOI: 10.1016/j.isci.2021.103163] [Reference Citation Analysis]
12 Bélanger É, Laprise C. Could the Epigenetics of Eosinophils in Asthma and Allergy Solve Parts of the Puzzle? Int J Mol Sci 2021;22:8921. [PMID: 34445627 DOI: 10.3390/ijms22168921] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Du L, Chen F, Xu C, Tan W, Shi J, Tang L, Xiao L, Xie C, Zeng Z, Liang Y, Guo Y. Increased MMP12 mRNA expression in induced sputum was correlated with airway eosinophilic inflammation in asthma patients: evidence from bioinformatic analysis and experiment verification. Gene 2021;:145896. [PMID: 34384863 DOI: 10.1016/j.gene.2021.145896] [Reference Citation Analysis]
14 Kuang FL, Bochner BS. Lessons learned from targeting eosinophils in human disease. Semin Immunopathol 2021;43:459-75. [PMID: 33891135 DOI: 10.1007/s00281-021-00849-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Asano T, Nanamiya R, Takei J, Nakamura T, Yanaka M, Hosono H, Tanaka T, Sano M, Kaneko MK, Kato Y. Development of Anti-Mouse CC Chemokine Receptor 3 Monoclonal Antibodies for Flow Cytometry. Monoclon Antib Immunodiagn Immunother 2021;40:107-12. [PMID: 33877898 DOI: 10.1089/mab.2021.0009] [Reference Citation Analysis]
16 Iype J, Fux M. Basophils Orchestrating Eosinophils' Chemotaxis and Function in Allergic Inflammation. Cells 2021;10:895. [PMID: 33919759 DOI: 10.3390/cells10040895] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Salter BM, Ju X, Sehmi R. Eosinophil Lineage-Committed Progenitors as a Therapeutic Target for Asthma. Cells 2021;10:412. [PMID: 33669458 DOI: 10.3390/cells10020412] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Li S, Liu F, Pei Y, Dong Y, Shang Y. Parathyroid hormone type 1 receptor regulates osteosarcoma K7M2 Cell growth by interacting with angiotensinogen. J Cell Mol Med 2021;25:2841-50. [PMID: 33511766 DOI: 10.1111/jcmm.16314] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Vanderhaegen T, Gengler I, Dendooven A, Chenivesse C, Lefèvre G, Mortuaire G. Eosinophils in the Field of Nasal Polyposis: Towards a Better Understanding of Biologic Therapies. Clinic Rev Allerg Immunol. [DOI: 10.1007/s12016-021-08844-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Zhang YH, Li Z, Zeng T, Chen L, Li H, Huang T, Cai YD. Detecting the Multiomics Signatures of Factor-Specific Inflammatory Effects on Airway Smooth Muscles. Front Genet 2020;11:599970. [PMID: 33519902 DOI: 10.3389/fgene.2020.599970] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
21 Zhong W, Zhang X, Zeng Y, Lin D, Wu J. Recent applications and strategies in nanotechnology for lung diseases. Nano Res 2021;:1-23. [PMID: 33456721 DOI: 10.1007/s12274-020-3180-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Eiger DS, Boldizsar N, Honeycutt CC, Gardner J, Rajagopal S. Biased agonism at chemokine receptors. Cell Signal 2021;78:109862. [PMID: 33249087 DOI: 10.1016/j.cellsig.2020.109862] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
23 Pinheiro-Torres AS, Ferreira-Duarte AP, Takeshita WM, Gushiken VO, Roncalho-Buck IA, Anhê GF, Antunes E, DeSouza IA. Airways exposure of bacterial superantigen SEB enhances bone marrow eosinophil population and facilitates its egress to blood and lung tissue. Life Sci 2021;264:118685. [PMID: 33137369 DOI: 10.1016/j.lfs.2020.118685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Pisani A, Pompa PP, Bardi G. Potential Applications of Nanomaterials to Quench the Cytokine Storm in Coronavirus Disease 19. Front Bioeng Biotechnol 2020;8:906. [PMID: 32974295 DOI: 10.3389/fbioe.2020.00906] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Peng F, Zhang W, Qiu F. Self-assembling Peptides in Current Nanomedicine: Versatile Nanomaterials for Drug Delivery. Curr Med Chem 2020;27:4855-81. [PMID: 31309877 DOI: 10.2174/0929867326666190712154021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
26 Sadee W, Oberdick J, Wang Z. Biased Opioid Antagonists as Modulators of Opioid Dependence: Opportunities to Improve Pain Therapy and Opioid Use Management. Molecules 2020;25:E4163. [PMID: 32932935 DOI: 10.3390/molecules25184163] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
27 Klion AD, Ackerman SJ, Bochner BS. Contributions of Eosinophils to Human Health and Disease. Annu Rev Pathol Mech Dis 2020;15:179-209. [DOI: 10.1146/annurev-pathmechdis-012419-032756] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 18.0] [Reference Citation Analysis]
28 Mitarotonda R, Giorgi E, Desimone MF, De Marzi MC. Nanoparticles and Immune Cells. CPD 2019;25:3960-82. [DOI: 10.2174/1381612825666190926161209] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Onyema OO, Guo Y, Hata A, Kreisel D, Gelman AE, Jacobsen EA, Krupnick AS. Deciphering the role of eosinophils in solid organ transplantation. Am J Transplant 2020;20:924-30. [PMID: 31647606 DOI: 10.1111/ajt.15660] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Klion AD, Rothenberg ME. Advances in eosinophilic diseases in 2018. J Allergy Clin Immunol 2019;144:1490-4. [PMID: 31655098 DOI: 10.1016/j.jaci.2019.10.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
31 Pease JE, Williams TJ. Tipping the balance: A biased nanobody antagonist of CCR3 with potential for the treatment of eosinophilic inflammation. J Allergy Clin Immunol 2019;143:552-3. [PMID: 30452926 DOI: 10.1016/j.jaci.2018.10.052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]